ImmuCell appoints two new independent directors; three directors retire effective April 15, 2026

IMMUCELL CORP /DE/

Bryan Gathagan, Michael Brigham, and Bobbi Jo Brockmann retire from board effective April 15, 2026.
Gilles Guillemette DVM and Anthony DiMarco Ph.D. elected as new directors effective same date.
Board moves to 7 members with 6 independent directors; CEO remains only non-independent.
New Strategy & Technology Committee formed; Guillemette chairs it; DiMarco serves on it.
Guillemette has 30+ years animal health executive experience; DiMarco 40 years biologics R&D.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.